Search Medical Condition
Please enter condition
Please choose location

Seongnam-si, Gyeonggi-do, Korea, Republic of Clinical Trials

A listing of Seongnam-si, Gyeonggi-do, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (138) clinical trials

Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence

- Post prostatectomy urinary incontinence (PPI) was common complication after radical prostatectomy among prostate cancer patients. - The prevalence of post-prostatectomy urinary incontinence was reported at 87%. - The pelvic floor muscle therapy (PFMT) using Kegel exercise was first methods to prevent PPI after prostatectomy. - However, there was no ...

Phase N/A

0.0 miles

Learn More »

Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

A Multicenter, Prospective, Randomized, Open-label, Phase 4 Trial Designed to Evaluate the Efficacy of the Timing of the Administration of a Telmisartan/S-Amlodipine(Telminuvo®Tab. 40/2.5mg) on 24-hour BP Control in Hypertensive Patients Inadequately Controlled by Telmisartan Monotherapy

Phase

0.0 miles

Learn More »

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

If testing has not already been performed, the study will provide for the testing.

Phase

0.0 miles

Learn More »

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone

This is a multi-center, randomized, open-label, Phase 3 study comparing Pexa Vec followed by sorafenib versus sorafenib in patients with advanced HCC without prior systemic therapy. A total of 600 patients will be randomly assigned to 2 treatment arms in a 1:1 ratio (300 in each arm) to reach at ...

Phase

0.0 miles

Learn More »

Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes

This is a phase 3 trial to evaluate the safety and efficacy of YH14755 in subjects with dyslipidemia and Type II Diabetes. In YH14755 treatment group, 88 subjects will be assigned and the subjects administer YH14755 for 16 weeks. In Metformin treatment group, 88 subjects will be assigned and the ...

Phase

0.0 miles

Learn More »